RSS-Feed abonnieren

DOI: 10.1055/a-2687-0506
A Novel Lymphosome-Based Long-Lasting Rat Tail Model of Lymphedema
Funding Ministry of Science and Technology of the People's Republic of China. National Natural Science Foundation of China. 82260391. 82372541. Talent Team Construction Project for Basic and Clinical Research on Lymphedema of Guizhou Province x. Qiankehe Talent CXTD [2025] 051.

Abstract
Background
Secondary extremity lymphedema is a chronic and progressive condition caused by obstructed lymphatic drainage, commonly following lymphadenectomy, infection, or trauma. Rodent models are preferred for experimental lymphedema research due to cost-effectiveness and reproducibility. Currently, rat tail models encounter limitations due to transient swelling and their inability to fully replicate the comprehensive pathophysiology of lymphedema, particularly concerning the effects of lymph node removal.
Methods
We developed a series of rat tail lymphedema models incorporating skin resection, deep lymphatic vessel disruption, and gluteal lymph node (GLN) excision to assess effects on lymphatic architecture, inflammation, and fibrosis. Indocyanine green (ICG) lymphography was used to visualize lymphatic function. Tail volume and circumference were measured weekly, and histological assessments quantified fibrosis and fibroadipose thickening. Bulk RNA sequencing was performed to characterize the inflammatory processes triggered by GLN removal.
Results
The combined model (skin removal, deep lymphatic disruption, and GLN excision) resulted in severe and persistent lymphedema marked by progressive swelling and pronounced fibrosis. ICG lymphography confirmed disruption of superficial lymphatic flow with partial recanalization of deep channels. Notably, lymphangiogenesis was observed at the GLN excision site, forming compensatory pathways connecting the tail to the popliteal lymph nodes. Histology revealed extensive collagen deposition and fibroadipose thickening in groups with lymph node removal, with the combined model showing the most pronounced changes. Bulk RNA-sequencing confirmed the removal of GLN involving the inflammatory and fibrosis process in the tail model.
Conclusion
This lymphosome-based rat tail model successfully replicates key features of lymphedema, including sustained swelling, lymphatic disruption, inflammation, and fibrosis.
‡ These authors contributed equally to this article.
Publikationsverlauf
Eingereicht: 01. Mai 2025
Angenommen: 17. August 2025
Accepted Manuscript online:
21. August 2025
Artikel online veröffentlicht:
03. September 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Dayan JH, Ly CL, Kataru RP, Mehrara BJ. Lymphedema: Pathogenesis and novel therapies. Annu Rev Med 2018; 69 (01) 263-276
- 2 Stanek K, Jonas F, Ticha P, Molitor M, Mestak O. Animal models used in the research of vascularized lymph node transfer: A systematic review. J Surg Res 2022; 272: 1-8
- 3 Bucan A, Frendø M, Ngo MT, Sørensen JA, Hölmich LR. Surgical lymphedema models in the mice hindlimb-A systematic review and quality assessment. Microsurgery 2024; 44 (01) e31088
- 4 Brower M, Grace M, Kotz CM, Koya V. Comparative analysis of growth characteristics of Sprague Dawley rats obtained from different sources. Lab Anim Res 2015; 31 (04) 166-173
- 5 Harb AA, Levi MA, Corvi JJ. et al. Creation of a rat lower limb lymphedema model. Ann Plast Surg 2020; 85 (S1): S129-S134
- 6 Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer 2007; 109 (12) 2607-2614
- 7 DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013; 14 (06) 500-515
- 8 Suami H, Chang DW, Matsumoto K, Kimata Y. Demonstrating the lymphatic system in rats with microinjection. Anat Rec (Hoboken) 2011; 294 (09) 1566-1573
- 9 Melo-Silva CR, Sigal LJ. Innate and adaptive immune responses that control lymph-borne viruses in the draining lymph node. Cell Mol Immunol 2024; 21 (09) 999-1007
- 10 Jeong HH, Kim D, Kim T. et al. The role of escin as a topical agent for lymphedema treatment in a rat model. Int J Low Extrem Wounds 2023; 15 347346231195944
- 11 Liu Z, Li J, Bian Y, Zhang X, Cai X, Zheng Y. Low-intensity pulsed ultrasound reduces lymphedema by regulating macrophage polarization and enhancing microcirculation. Front Bioeng Biotechnol 2023; 11: 1173169
- 12 Wei M, Wang L, Liu X. et al. Metformin eliminates lymphedema in mice by alleviating inflammation and fibrosis: implications for human therapy. Plast Reconstr Surg 2024; 154 (06) 1128e-1137e
- 13 Wei M, Wang L, Wu X. et al. Synchronous supraclavicular vascularized lymph node transfer and liposuction for gynecological cancer-related lower extremity lymphedema: A clinical comparative analysis of three different procedures. J Vasc Surg Venous Lymphat Disord 2024; 12 (05) 101905
- 14 Maruccia M, Giudice G, Ciudad P. et al. Lymph node transfer and neolymphangiogenesis: From theory to evidence. Plast Reconstr Surg 2023; 152 (05) 904e-912e
- 15 Lu JH, Hsia K, Su CK. et al. A novel dressing composed of adipose stem cells and decellularized Wharton's jelly facilitated wound healing and relieved lymphedema by enhancing angiogenesis and lymphangiogenesis in a rat model. J Funct Biomater 2023; 14 (02) 104
- 16 Kawai Y, Shiomi H, Abe H, Naka S, Kurumi Y, Tani T. Cell transplantation therapy for a rat model of secondary lymphedema. J Surg Res 2014; 189 (01) 184-191
- 17 Saito Y, Nakagami H, Morishita R. et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 2006; 114 (11) 1177-1184
- 18 Onishi T, Nishizuka T, Kurahashi T. et al. Topical bFGF improves secondary lymphedema through lymphangiogenesis in a rat tail model. Plast Reconstr Surg Glob Open 2014; 2 (08) e196
- 19 Hsu JF, Yu RP, Stanton EW, Wang J, Wong AK. Current advancements in animal models of postsurgical lymphedema: A systematic review. Adv Wound Care (New Rochelle) 2022; 11 (08) 399-418
- 20 Hadrian R, Palmes D. Animal models of secondary lymphedema: New approaches in the search for therapeutic options. Lymphat Res Biol 2017; 15 (01) 2-16
- 21 Podder PS, Bhadra D, Pal S, Klimberg VS, Stolarz AJ. Clinical relevance of animal models of lymphatic dysfunction and lymphedema. Microcirculation 2025; 32 (04) e70009
- 22 Rockson SG. Advances in lymphedema. Circ Res 2021; 128 (12) 2003-2016
- 23 Iyer D, Jannaway M, Yang Y, PScallan J. Lymphatic valves and lymph flow in cancer-related lymphedema. Cancers (Basel) 2020; 12 (08) 2297
- 24 Kang HJ, Moon SY, Kim BK, Myung Y, Lee JH, Jeong JH. Recellularized lymph node scaffolds with human adipose-derived stem cells enhance lymph node regeneration to improve lymphedema. Sci Rep 2023; 13 (01) 5397
- 25 Martini F, Meroni M, Scaglioni MF. Pedicled SCIP-based vascularized lymph node and lymphatic vessels transfer (VLNT and VLVT) for deep lymphatic system reconstruction and dead space obliteration after medial thigh sarcoma resection: A case report. Microsurgery 2024; 44 (05) e31205